Roquefort Therapeutics Plc (ROQ)
Market Closed
8 Dec, 15:30
LSE LSE Primary 1. 35
GBX 0
0%
4.97M Market Cap
- P/E Ratio
0% Div Yield
3,754,930 Volume
- Eps
1.35 GBX
Previous Close Day Range
1.3 1.4
Year Range
1.08 5.5
Want to track ROQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ROQ Roquefort Therapeutics Plc 25 Sep 2025 | | - | - |
| ROQ Roquefort Therapeutics Plc 24 Apr 2025 | | - | - |
| ROQ Roquefort Therapeutics Plc 25 Sep 2024 | | - | - |
| ROQ Roquefort Therapeutics Plc 28 Jun 2024 | | - | - |
ROQ Earnings Reports FAQ
What is the earnings per share (EPS) for ROQ?
EPS data for ROQ is currently not available, as Roquefort Therapeutics Plc has not reported recent earnings.
What is the company's earnings growth rate?
Roquefort Therapeutics Plc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Roquefort Therapeutics Plc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Roquefort Therapeutics Plc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ROQ at this time, as Roquefort Therapeutics Plc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
